Adverse Event Reporting

• CDC's Selected Adverse Events Reported after COVID-19 Vaccination has information for patients about adverse events reported after vaccination such as anaphylaxis, thrombosis with thrombocytopenia and myocarditis.
• Monitoring COVID-19 Vaccine Safety: VAERS and V-SAFE (December 10, 2020)
  Hear from Tanya Myers, PhD, MSc, the v-safe team lead for the CDC, as she provides a brief overview of two vaccine safety monitoring platforms pharmacists should be aware of.(APhA Weekly Open Forum Webinar Excerpt - Video - Slides)

Billing & Payment

• Reference CMS information about Billing Changes for Medicare Advantage Plans.
• Reimbursement for Administration of COVID-19 Vaccine(s)—What We Know (September 22, 2021)
  This resource provides an overview of what we know about COVID-19 vaccine reimbursement at this time and covers steps pharmacists can take now to be positioned as a COVID-19 vaccine provider. (APhA Know the Facts - PDF)
• HRSA COVID-19 Uninsured Program and Coverage Assistance Fund: Updates for Pharmacy (June 4, 2021)
  This resource provides an overview of what we know about COVID-19 vaccine reimbursement at this time and covers steps pharmacists can take now to be positioned as a COVID-19 vaccine provider. (APhA Know the Facts - PDF)
• *As of October 6, 2023, The US government is no longer purchasing COVID-19 vaccines; therefore, the CDC COVID-19 Vaccination Program has ended. Updated 2023–2024 COVID-19 vaccines are now available for private purchase in the commercial marketplace. More information can be found here: https://www.cdc.gov/vaccines/covid-19/vaccination-provider-support.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Fretail-pharmacy-program-faq.html
• CMS's Medicare Payment for COVID-19 Vaccination Administration in the Home has important updates on increased reimbursement for at-home COVID-19 vaccinations.
• NCPDP’s Emergency Preparedness Guidance (Version 1.13)